{"id":"W145182321","doi":"10.1177/1756285608098359","title":"Review: Escalating immunotherapy of multiple sclerosis","year":2008,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Natalizumab; Glatiramer acetate; Alemtuzumab; Multiple sclerosis; Mitoxantrone; Immunotherapy; Clinical trial; Disease; Intensive care medicine; Fingolimod; Oncology; Immunosuppression; Immunology; Internal medicine; Transplantation; Chemotherapy; Immune system","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002640809,0.0002245795,0.0006598866,0.0001054838,0.0001054037,0.000002269894,0.000215836,0.00007624721,0.0001497237],"category_scores_gemma":[0.0006525566,0.0001627795,0.0001837269,0.0005061681,0.0006861428,0.0001313736,0.00008062406,0.0003933916,0.000009608471],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001564518,"about_ca_system_score_gemma":0.00002571811,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001647361,"about_ca_topic_score_gemma":0.00002058452,"domain_scores_codex":[0.9980313,0.000208541,0.0005398525,0.0003880032,0.0003924012,0.0004399414],"domain_scores_gemma":[0.9986218,0.0007292136,0.0001416987,0.0003656647,0.00006826252,0.00007339762],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0008964934,0.0006851364,0.5399066,0.0005049542,0.00004822669,0.000008585545,0.0001937705,0.0001784693,0.007833459,0.00003964134,0.000081274,0.4496233],"study_design_scores_gemma":[0.003615209,0.001172282,0.9696761,0.000731168,0.000020186,0.00001320926,0.00004956846,0.001463836,0.0003087946,0.0005423289,0.02217387,0.0002334739],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6556073,0.3366508,0.0007108775,0.002831666,0.0000962487,0.00147333,0.000007222408,0.0001151594,0.00250737],"genre_scores_gemma":[0.5691925,0.4279246,0.0005259254,0.002247647,0.00001274478,0.00006721311,0.000002481851,0.00001447309,0.00001244405],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4493899,"threshold_uncertainty_score":0.6637957,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08269379223139042,"score_gpt":0.3385518491725664,"score_spread":0.2558580569411759,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}